As one of the most influential and troublesome human pathogens, Acinetobacter baumannii
(A. baumannii) has emerged with many multidrug-resistant strains. After collecting 33 …

To enhance the utility of the genetically diverse panel of Acinetobacter baumannii isolates
reported recently by Galac and coworkers (MR Galac, E. Snesrud, F. Lebreton, J. Stam, et …

A computational method has been developed to distinguish the Klebsiella species serotypes
to aid in outbreak surveillance. A reliability score (estimated based on the accuracy of a …

Vaccines and monoclonal antibodies are promising approaches for preventing and treating
infections caused by multidrug resistant Acinetobacter baumannii. However, only partial …

The clinical isolation rate of multidrug-resistant or pan-resistant Acinetobacter baumannii (A.
baumannii) is increasing, resulting that optional antibiotics are very limited in clinical …

Antibiotic resistance (AR) is the result of microbes' natural evolution to withstand the action
of antibiotics used against them. AR is rising to a high level across the globe, and novel …

Acinetobacter baumannii is a multiresistant opportunistic nosocomial pathogen. A protein
fraction was purified and analyzed by 2‐DE. Twenty‐nine major protein spots were selected …

The genus Acinetobacter comprises species with ecological significance and opportunistic
pathogens and has a complicated taxonomy. Precise species identification is a foundation …

A. baumannii is an emerging nosocomial pathogen associated with health care units. Its
resistance to various antibiotics gives rise to the need of vaccine development against it …

Multidrug-resistant Acinetobacter baumannii (A. baumannii) infections are becoming more
prevalent all over the world. As a cost-effective and preventative method, vaccination seems …